Request Quote
Wound Care
Gauze SeriesSwabs, sponges, rolls & pads
Wound DressingFoam, film, island & non-adherent
Cotton SeriesAbsorbent wool & cotton pads
Surgical & Dental
Surgical ConsumablesLap sponges, drapes & OR towels
Dental ConsumablesCotton rolls, bibs & sponges
Dressing PacksPre-assembled sterile kits
Bandage & PPE
Bandage SeriesCrepe, elastic, PBT & gauze
Adhesive SeriesTapes, plasters & zinc oxide
Non-woven SeriesCaps, gowns & sponges
First Aid SeriesKits, bags & compress bandages
 View All Products
Why Kingphar
35+ Years of
Medical Excellence

ISO 13485 certified. CE, FDA & SFDA registered. Trusted by distributors in 60+ countries.

Get a Quote
Learn
News CenterIndustry updates & product launches
Buying GuidesIn-depth procurement guides
Technical
Operation ManualsProduct usage & clinical procedures
Knowledge BaseStandards & regulations
Downloads
Certificates &
Documents

ISO, CE, FDA certificates and product specification sheets.

Browse Documents
Products
Resources
News Center Buying Guides Operation Manuals Documents
Company
About Us Certificates Contact
Request Quote
Kingphar Medical Group

New's

12/3 2026

Sourcing Non-woven Medical Products from China: OEM & Quality Audit Guide 2026
Sourcing Guide · Non-woven Series · March 2026

Sourcing Non-woven Medical Products
from China: OEM & Quality Audit Guide 2026

20 min read
By Albar · Kingphar Medical
50-Point Interactive Audit Checklist

China manufactures the majority of the world's non-woven medical products — isolation gowns, spunlace gauze sponges, underpads, surgical drapes. The quality range among factories is wide. This guide gives buyers the tools to qualify the right manufacturer the first time: a structured OEM process, a 50-point factory audit checklist, and a complete documentation roadmap for CE and GCC market compliance.

50
Audit Points
6
Audit Categories
35–60
OEM Days
GCC + CE
Markets Covered
Section 01

China Non-woven Manufacturing Landscape

China's non-woven medical product industry is concentrated in three primary manufacturing clusters: Guangdong Province (isolation gowns, surgical drapes, spunlace products), Jiangsu Province (spunlace fabric rolling, gauze sponge finishing), and Shandong Province (cotton-based products, mixed non-woven-cotton lines). Each cluster has different strengths, different typical price points, and different levels of international certification penetration.

ClusterPrimary ProductsInternational Cert PrevalencePrice LevelNotes
GuangdongSMS/SMMS gowns, surgical drapes, non-woven compositesHigh — many ISO 13485 + CE certifiedMid to highMost export-oriented factories; strongest in gowns and PPE
JiangsuSpunlace fabric, gauze sponge finishing, lap spongesMedium — growing ISO 13485 adoptionMidStrong spunlace production capacity; some vertically integrated from fibre to finished product
ShandongGauze sponges (woven + non-woven), cotton products, first aid suppliesMedium — many have BP CoA capabilityLow to midCotton-centric; non-woven lines often added alongside existing woven gauze production

The most important practical distinction is not between provinces but between two factory types: integrated manufacturers (who produce fabric in-house and convert to finished product) and converters (who buy fabric from fabric mills and perform cutting, folding, packaging, and possibly sterilisation). Integrated manufacturers offer better quality control over the full supply chain but typically have higher MOQs. Converters are more flexible but introduce a supply chain link where specification control can break down.

⚠️
The Trading Company ProblemA significant portion of China's non-woven medical exports are shipped through trading companies — entities that hold no production capacity but source from multiple factories. Trading companies can reduce your per-unit cost by aggregating orders across buyers, but they also mean you have no direct relationship with the actual manufacturer, no ability to audit production directly, and often no visibility into which factory produced which lot. For regulated medical products, deal with manufacturers directly or use a trading company only when you have the right to audit and name the manufacturing facility in your regulatory documentation.
Section 02

OEM Process: 6 Stages from RFQ to Delivery

A well-structured OEM sourcing process reduces the risk of specification errors, production surprises, and documentation gaps that create problems at the destination market. The following 6-stage process maps the key activities, decisions, and document handoffs for a first-time OEM order with a China non-woven factory.

01
RFQ & Initial Supplier Qualification Days 1–7
Send a structured RFQ to 3–5 candidate factories including full product specification (fabric type, GSM, dimensions, performance standard, certifications required, sterile/non-sterile). Evaluate responses against a minimum qualification checklist before proceeding. Request: ISO 13485 certificate, NMPA production license, sample product test report from accredited lab.
Write full product specSend to 3–5 factoriesRequest ISO 13485 + NMPA docsEvaluate initial responses
02
Sample Order & Lab Testing Days 8–21
Order pre-production samples from 2–3 shortlisted factories. Test samples against specification — at minimum: GSM verification, dimensional accuracy, and for barrier products, hydrostatic pressure and bacterial filtration (require third-party accredited lab report). Evaluate sample quality against your specification before committing to a production order.
Order pre-production samplesGSM + dimensional checkThird-party barrier test (if applicable)Select preferred supplier
03
Factory Audit Days 14–28
For first-time orders above $10,000 FOB or for regulated products, conduct an on-site factory audit — either by your team, a third-party auditor (SGS, Bureau Veritas, Intertek), or via a structured video audit. Use the 50-point checklist in Section 03 of this guide. Document all findings and require a corrective action plan for any critical non-conformances before proceeding.
On-site or video audit50-point checklistCAR for critical findingsAudit report issued
04
PO Confirmation & Production Days 1–30 from PO
Issue a formal PO referencing the approved sample, full product specification, packaging requirements, labelling requirements, and documentation requirements. Confirm production start date and milestone schedule. For first production runs, arrange an in-process inspection at approximately 30–50% production completion to catch specification issues before the full run is complete.
Formal PO with full specLabel approvalIn-process inspection at 50%Production milestone sign-off
05
Pre-Shipment Inspection & Documentation Days 31–45 from PO
Before goods ship, conduct a pre-shipment inspection — AQL 2.5 sampling for dimensional and visual checks, plus lot-specific CoA review. For sterile products, obtain the sterilisation cycle report, sterility testing results, and bioburden data. Compile the full documentation package required for the destination market (see Section 05 of this guide).
AQL 2.5 inspectionLot CoA reviewSterilisation docs (if sterile)Full doc package compiled
06
Shipment & Incoming QC at Destination Days 46–60+ from PO
Confirm shipment documents (packing list, commercial invoice, CoO, Bill of Lading). On receipt, perform incoming inspection against the AQL-approved sample and specification — including GSM spot-check (see Section 07 of the GSM Guide) and visual inspection of labelling, packaging integrity, and product dimensions. Release to stock only after incoming inspection sign-off.
Shipment docs verifiedIncoming GSM spot-checkLabel + packaging checkIncoming inspection sign-off
Section 03

50-Point Factory Audit Checklist

Use this checklist during an on-site or video factory audit. Each item is marked with a criticality level: KD = Knock-down (automatic disqualify), HI = High (must resolve before order), MD = Medium (corrective action acceptable).

🔍 50-Point Non-woven Factory Audit Checklist
0 / 50
items verified
✓
ISO 13485:2016 certificate — valid, scope includes non-woven medical products KD
Verify expiry date and scope statement. Confirm issuing CB is IAF-accredited. Check CB's online portal by certificate number.
✓
NMPA (China) production license — valid, scope includes non-woven medical devices KD
Required for medical device production in China. Verify on China NMPA public database. Check specific product categories listed in scope.
✓
NMPA product registration for product categories being purchased KD
NMPA product registration (产品注册证) is separate from production license. Each product category requires its own registration. Request the registration certificate number and verify online.
✓
CE certificate or Declaration of Conformity (DoC) for EU/GCC market products HI
Class I non-sterile: self-declaration acceptable. Class I sterile or Class IIa: Notified Body involvement required. Verify NB number in EU NANDO database. GCC SFDA may require additional registration.
✓
Business license — valid, registered business address matches factory location HI
Mismatch between registered address and production site is a common indicator of a trading company claiming to be a manufacturer. Confirm both addresses.
✓
ISO 14001 environmental management certificate MD
Not mandatory for medical devices, but indicates a more systematically managed operation. Increasingly required by European hospital procurement sustainable sourcing policies.
✓
OEKO-TEX Standard 100 for skin-contact products (gauze sponges, wipes) MD
Tests fabric for harmful substances. Relevant for non-woven gauze, wipes, and products in direct prolonged skin contact. Verify on OEKO-TEX database by certificate number.
✓
EN 13795 or AAMI PB70 test report — from ISO 17025-accredited lab, within 24 months HI
Required for gowns and drapes claiming barrier performance. Verify the test lab's accreditation scope covers these specific test methods. Report must be performed on the fabric currently in production — not on an older fabric variant.
✓
Export license for medical devices — if applicable to destination market MD
China requires an export license for certain medical device categories. Confirm with the factory which products require export registration and verify documentation is in place.
✓
Production equipment matches claimed product range — SMS/SMMS line for gowns; spunlace line for gauze sponges KD
A factory claiming to manufacture SMS gowns must have SMS production machinery on-site or a documented supply relationship with a certified SMS fabric mill. Request to see the production line — not just the cutting and packaging area.
✓
Cleanroom or controlled production environment for sterile products HI
Sterile non-woven products require a cleanroom environment pre-sterilisation. Verify classification (ISO 8 minimum for non-sterile assembly, ISO 7 for terminal sterilisation assembly) and whether environmental monitoring data is maintained.
✓
Equipment maintenance records — calibrated, current HI
Check maintenance logs for cutting machines, sealing machines, packaging lines, and any testing equipment (scales, tensile testers). Gaps in maintenance records indicate QMS non-compliance.
✓
Fabric incoming inspection area and equipment — scale, GSM cutter, light table HI
Confirm the factory performs fabric GSM verification on receipt. Ask to see a recent fabric incoming inspection record. The absence of a fabric inspection process is a critical quality gap for converters.
✓
Production capacity stated matches claimed capacity — visible production lines MD
Factories frequently overstate production capacity. Count production lines and ask about shift patterns to verify whether stated capacity is plausible. A factory claiming 500,000 units/month with two cutting tables is overstating.
✓
Sterilisation capability — EtO or gamma — or documented relationship with certified sterilisation service HI
On-site EtO sterilisation requires separate NMPA registration. Off-site gamma sterilisation through a service provider is common and acceptable — but require the service provider's ISO 11137 validation documents.
✓
Packaging line — packaging material management, seal integrity testing for sterile products MD
For sterile products, seal integrity is critical. Verify that seal strength is tested per EN 868 or equivalent, and that packaging materials have their own incoming inspection records.
✓
Fire safety and emergency exit compliance — visible, current inspection certificate MD
Non-woven materials are flammable. Fire safety compliance is both a regulatory requirement and an indicator of overall facility management quality. Visible fire extinguishers, emergency exits, and inspection records are minimum evidence.
✓
Warehouse — temperature and humidity control records maintained; product segregation (raw material / in-process / finished / rejected) MD
Non-woven medical products require controlled storage conditions. Ask for warehouse temperature and humidity logs from the past 3 months. Absent segregation between rejected and approved stock is a serious QMS finding.
✓
QMS documented and implemented — not just certified on paper HI
Request to see 3 random SOPs and the corresponding training records showing operators have been trained. An ISO 13485 certificate without visible QMS implementation is a certificate of documentation, not quality.
✓
Lot traceability — each production lot traceable from raw material CoA to finished product CoA KD
Request to trace a specific finished lot back to its raw material lot. If the factory cannot demonstrate this traceability within 15 minutes of the request, the traceability system is inadequate.
✓
Non-conformance and CAPA (Corrective Action / Preventive Action) system active and documented HI
Request to see the CAPA log from the past 12 months. A factory with zero CAPAs in the past year either has a perfect production process (unlikely) or is not recording non-conformances (more likely). Both outcomes are concerning.
✓
Customer complaint handling procedure — documented, response time defined HI
Ask for a summary of complaints received in the past 12 months and their resolution. A factory that claims to receive zero complaints has either excellent quality or is not tracking complaints — verify which.
✓
Internal audit program — last internal audit within 12 months, findings documented MD
ISO 13485 requires annual internal audits. Request the last internal audit report and verify it was not conducted by the same person responsible for the area being audited.
✓
Management review meeting records — at least annual, attended by senior management MD
Management review is an ISO 13485 requirement. The record should show senior management engagement with quality metrics, complaint data, and audit findings — not a rubber-stamp exercise.
✓
Certificate of Analysis (CoA) — can be generated per lot, in English, with correct test parameters HI
Request to see a blank CoA template and a completed CoA for a recent production lot. Verify the CoA includes: lot number, production date, product specification, test results, and QC manager signature.
✓
Document control — SOPs, work instructions, and forms are version-controlled and current versions are in use on the production floor MD
Check 3 random work instructions against the document control log. If operators are using printed SOPs without version numbers, or using versions that differ from those in the document control system, document control is nominal only.
✓
Post-market surveillance / vigilance system in place for CE-marked products HI
EU MDR 2017/745 requires manufacturers of CE-marked devices to maintain a post-market surveillance plan and file periodic safety update reports (PSUR) or summary technical documentation (SSTD). Request evidence of the PMS plan.
✓
Approved Supplier List (ASL) — maintained, reviewed annually, suppliers audited HI
A well-managed non-woven factory will have 2–3 approved fabric suppliers per material type. Single-source fabric supply is a risk indicator. Request the ASL and ask when the last supplier audit was conducted.
✓
Fabric incoming inspection records — GSM verification, dimensional check, visual inspection per lot HI
Request fabric incoming inspection records for the past 3 months. Verify that every fabric lot received has a corresponding incoming inspection record before being released to production.
✓
Fabric supplier CoAs — received per lot, retained in QMS records MD
Fabric supplier CoAs are the first link in lot traceability. Verify that CoAs are received and filed per lot, not just for annual qualification audits.
✓
Fibre composition verification — confirmation of viscose-PET ratio for spunlace products HI
Ask how the factory verifies that 70/30 viscose-PET fabric is actually the specified composition — not a cheaper alternative composition. Acceptable methods: supplier CoA with fibre composition declaration, or annual third-party fibre analysis.
✓
Packaging material compliance — non-toxic, tested for compatibility with product and sterilisation method MD
For sterile products, packaging material must be validated as compatible with the sterilisation method. Request the packaging validation report or the packaging material supplier's declaration of compatibility.
✓
X-ray detectable thread supply chain — if applicable, thread supplier certified HI
X-ray detectable threads are a critical safety component. Verify the thread supplier is documented in the ASL and that a thread specification is included in the product's technical file.
✓
Rejected material quarantine — physically segregated and clearly labelled MD
Walk the warehouse and check that rejected materials are in a clearly labelled, physically separated area. Unsegregated rejected material is one of the most common audit findings and indicates a QMS that exists in documentation but not in practice.
✓
FIFO (First In, First Out) raw material management — rotation system documented and visible MD
Ask the warehouse team (not the QC team) how they manage stock rotation. If they cannot explain FIFO without prompting, it is likely not practiced.
✓
No child labour — age verification records available for all workers KD
Request to see the worker registration system and verify that age verification is performed at hiring. Any confirmed instance of underage workers is an immediate disqualification.
✓
Working hours and overtime records — within legal limits (max 60 hours/week with consent) HI
Request payroll and working hours records for the past 3 months. Systematic overtime in excess of legal limits is a social compliance failure and a worker welfare concern.
✓
Worker health and safety program — PPE provided, first aid available, incident log maintained HI
Observe workers on the production floor — are they wearing appropriate PPE (gloves, hairnets, masks)? Is first aid equipment visible and accessible? Ask to see the incident and near-miss log.
✓
BSCI, SA8000, or equivalent social audit certificate — current MD
Increasingly required by European and US hospital procurement sustainable sourcing policies. A current BSCI or SA8000 certificate reduces the need for a standalone social compliance audit but does not eliminate it.
✓
No forced or involuntary labour — worker contracts voluntary, freedom of movement unrestricted KD
Verify that workers are employed voluntarily and that there are no indications of restricted freedom of movement. Document inspection — are contracts in workers' own possession?
✓
Minimum wage compliance — workers paid at or above local legal minimum wage HI
Request payroll records for the past 3 months and verify against the applicable local minimum wage. Include piece-rate workers in the calculation.
✓
Training records — operators trained on production procedures, QC requirements, and safety MD
Request training records for 3 randomly selected production operators. Verify that training covers the specific product being audited — generic training records are insufficient.
✓
English-language communication capability — sales / QC contact can respond substantively to technical specification questions HI
Test this during the audit. Pose a specific technical question about fabric GSM or sterilisation validation. A factory where no one can answer technical questions in English will create specification misalignment during the OEM process.
✓
Sample capability — can produce pre-production samples to buyer specification HI
Confirm the factory can produce samples before committing to a production run. A factory unwilling to invest in a pre-production sample is either a trading company, is producing a generic standard product, or has low confidence in meeting your specification.
✓
Custom packaging and labelling capability — can print to buyer's label specifications MD
Request to see examples of custom-labelled products the factory has produced. Verify that label printing is done in-house or at a documented, audited subcontractor — not an unchecked print shop.
✓
Previous OEM references — can provide contact details for 2 international buyers (non-Chinese) HI
Request to contact two existing international buyers. A factory unable or unwilling to provide references from international clients is either new to export, has had problems with previous clients, or is concealing its actual customer base.
✓
MOQ and production scheduling — realistic MOQ confirmed; production schedule communicated clearly MD
Confirm the MOQ is genuinely achievable and not artificially low as a sales tactic. Request a production schedule for your order based on the factory's current order book.
✓
Subcontracting policy — if any process is subcontracted, subcontractors are documented and audited HI
ISO 13485 requires that all subcontracted processes are controlled. Common subcontracted processes include sterilisation, printing, and certain cutting operations. Request the subcontractor list and the last audit of each subcontractor.
✓
Pre-shipment inspection acceptance — willing to allow buyer or third-party inspector access before shipment HI
A factory that refuses to allow pre-shipment inspection by the buyer or their appointed inspector should not receive a purchase order. This is non-negotiable for first-time orders and should remain a standard practice for all subsequent orders.
✓
Banking and payment terms — supports standard international payment instruments (L/C, T/T) MD
Verify the factory can support a Letter of Credit if required. For first orders, a 30% deposit / 70% before shipment T/T arrangement is standard — be cautious of factories requiring 100% prepayment before sample approval.
Section 04

Required Certifications Explained

Non-woven medical product procurement involves a hierarchy of certification requirements that many buyers conflate. Understanding what each certificate actually covers — and what it does not — prevents both over-specification (demanding unnecessary certifications) and under-specification (accepting certificates that don't cover the products ordered).

CertificateWhat It ConfirmsWhat It Does Not ConfirmVerify How
ISO 13485:2016The factory has a documented quality management system for medical device production, audited by an accredited CBProduct quality, product specification compliance, or that specific products meet clinical performance standardsCB's online certificate database by certificate number
NMPA Production LicenseThe factory is legally registered to manufacture medical devices in China in the stated product categoriesExport compliance, CE, or any destination-market regulatory approvalChina NMPA public database (国家药监局)
CE Declaration of ConformityThe manufacturer declares the product meets EU essential requirements (Class I); or Notified Body has reviewed the technical file (Class IIa+)For Class I products: independent verification of claims. Self-declaration requires no third-party validation.EU NANDO database (for NB-involved products); cross-check CE Technical File exists
EN 13795 Test ReportThe specific fabric lot tested meets the standard's performance requirements on the stated test dateThat current production uses the same fabric. Lab reports can be misrepresented as covering different fabric variants.ISO 17025 lab accreditation scope; compare fabric spec in report to fabric spec on current production CoA
BP Certificate of AnalysisThe specific product lot meets BP monograph parameters (thread count for woven; GSM/fibre shedding for non-woven)Ongoing production quality — a CoA is lot-specific. It provides no assurance about other lots.Request lot-specific CoA, not a general product certificate; verify test values match BP monograph requirements
Section 05

Documentation for GCC & CE Markets

🏥
GCC / SFDA Market
Mandatory
CE certificate or equivalent approval document
ISO 13485 certificate — must cover product category
Lot-specific CoA for each shipment
Certificate of Origin (CoO) — Form A or CCPIT stamped
Technical data sheet in English
SFDA/MOHAP product registration (country-specific)
🇪🇺
EU Market (CE MDR)
Mandatory
Declaration of Conformity per EU MDR 2017/745
Technical File (Class I) or CE certificate + NB involvement (Class IIa)
EU Authorised Representative (if non-EU manufacturer)
UDI — Unique Device Identifier on labelling
Post-Market Surveillance Plan
💉
Sterile Products (additional)
Mandatory
Sterilisation validation report (ISO 11135 for EtO; ISO 11137 for gamma)
Sterility test per lot (SAL 10⁻⁶)
Bioburden testing pre-sterilisation
Packaging validation report (EN 868)
EtO residual test for EtO-sterilised products (EN ISO 10993-7)
⚗️
EN 13795 Gowns / Drapes
Recommended
EN 13795-1/2 test report from ISO 17025-accredited lab
Fabric GSM certificate per lot
Seam integrity test report (for high-performance gowns)
Fabric construction verification (SMS vs SMMS — layer count)
Section 06

10 Red Flags to Reject Immediately

🚩
ISO 13485 certificate scope does not include non-woven medical products
A factory may hold a valid ISO 13485 certificate for gauze bandages or cotton swabs that does not cover isolation gowns or spunlace gauze sponges. Always read the scope statement — certificates without the specific product category are of limited value for that product.
🚩
Factory cannot trace a specific lot from finished product to raw material within 15 minutes
Lot traceability is a fundamental GMP requirement. If the factory QC team struggles to pull up the raw material CoA for a specific finished lot number, the traceability system is either non-functional or exists only in paperwork.
🚩
EN 13795 test report is for a fabric variant not currently in production
This is the most common documentation fraud in gown procurement. The test report was performed on a 60 GSM SMMS fabric; current production uses 45 GSM SMS. Always compare the fabric specification in the test report with the current production CoA.
🚩
Factory refuses pre-shipment inspection
No legitimate manufacturer of regulated medical products will refuse a buyer's right to inspect before shipment. Any refusal — regardless of the justification offered — is a disqualifying event for the order.
🚩
Production capacity claimed is physically inconsistent with visible equipment
Four cutting tables cannot produce one million isolation gowns per month. If claimed capacity and visible production infrastructure are inconsistent, the factory is either a trading company or is producing through undisclosed subcontractors.
🚩
Fabric incoming inspection records do not exist or are clearly backdated
A converter that does not inspect incoming fabric has no visibility into the specification of the primary raw material. Backdated records — identifiable by identical handwriting, implausible timestamps, or sequential lot numbers recorded on the same date — indicate document fabrication.
🚩
CAPA system shows zero corrective actions in the past 12 months
Any production operation generates non-conformances. A factory reporting zero CAPAs in a year either does not record non-conformances or is presenting a curated record. Either indicates a QMS that does not function as intended.
🚩
Rejected materials are stored unsegregated from approved stock
Physical segregation of rejected material is a basic GMP requirement. If rejected material is stored near, adjacent to, or intermingled with approved stock, the risk of inadvertent shipment of rejected product is real and uncontrolled.
🚩
Sterilisation is claimed but no sterilisation validation report exists
Claiming sterility without a validation report is a regulatory violation. EtO sterilisation requires validation per ISO 11135; gamma per ISO 11137. Both require bioburden characterisation, dose mapping, and cycle validation — a multi-month process. A factory that began offering sterile products recently without these documents has not performed the required validation.
🚩
Cannot provide contact details for two verifiable international buyers
References are the simplest external quality signal. A manufacturer with a strong track record of supplying regulated markets will have references. Unwillingness or inability to provide them warrants significant additional scrutiny before commitment.
Non-woven Buyer's Guide NW vs Woven Gauze GSM Spec Guide Isolation Gown Non-woven Sponge Start Your OEM Enquiry
Section 07

Frequently Asked Questions

The minimum certification baseline is: (1) ISO 13485:2016 with scope explicitly covering non-woven medical products; (2) China NMPA production license and product registration for the specific categories being sourced; (3) CE under EU MDR 2017/745 for EU or GCC market products. Class I non-sterile products require self-declaration only; Class IIa products require Notified Body involvement. Beyond these mandatory certifications, look for ISO 14001, BSCI or equivalent social audit, and OEKO-TEX Standard 100 for skin-contact products. Verify every certificate directly with the issuing body's verification portal — never accept a certificate copy without independent verification.
Typical OEM lead time for a qualified China factory is 35–60 days from PO confirmation to goods ready for inspection. This breaks down as: raw material procurement and incoming inspection (5–10 days), production run (15–25 days), QC testing and internal inspection (5–7 days), pre-shipment inspection and documentation (5–10 days). For sterile products, add 10–20 days for the sterilisation cycle and sterility release testing. Custom packaging, unique labelling requirements, or first-time OEM development (new product, no existing approved sample) add 10–20 days to the pre-production phase. GCC market orders requiring SFDA or MOHAP registration documentation should build in additional time for document compilation.
Verification steps: (1) Identify the issuing certification body (CB) on the certificate. (2) Confirm the CB is accredited by an IAF member accreditor — in China typically CNAS, internationally TÜV, SGS, Bureau Veritas, Intertek, BSI. (3) Visit the CB's online certificate verification portal and search by the certificate number. (4) Confirm the scope covers the specific product category you are purchasing — ISO 13485 scope can be narrow, and the factory may hold a valid certificate that excludes non-woven products. (5) Check the certificate expiry date and that the last surveillance audit was within the past 12 months. A certificate that passed its last surveillance audit 18 months ago is approaching or already past renewal — the factory may have lost the certificate without updating their documentation.
A video audit is significantly better than no audit and is now accepted practice for initial qualification in many hospital procurement systems, particularly following supply chain disruptions. The limitations of video audits are: the factory controls camera angles and may avoid showing problematic areas; documents can be prepared in advance and selectively shown; physical conditions (material segregation, facility condition) are harder to assess without presence. Best practice is to use a video audit for initial screening (using the 50-point checklist in this guide as your framework), and to commit to an on-site audit before significant order volume commitment. For orders above $50,000 FOB or for regulated products destined for EU or GCC hospital formularies, an on-site audit by a qualified auditor — your own staff, or a third-party auditing firm — is strongly recommended.
A

Albar

Content Auditor & Content Operations · Kingphar Medical

Albar leads content operations at Kingphar Medical. This OEM sourcing guide reflects Kingphar's experience as both a China non-woven manufacturer supplying international buyers and as a buyer qualifying sub-tier suppliers — including ISO 13485 surveillance audits, EN 13795 compliance projects, and GCC documentation preparation for Saudi, UAE, and Qatar markets.

Connect on LinkedIn
📚 Standards & References
  1. ISO 13485:2016 — Medical devices quality management systems. iso.org
  2. EU MDR 2017/745 — Medical device regulation. eur-lex.europa.eu
  3. EN 13795-1/2 — Surgical gowns and drapes, performance requirements. cen.eu
  4. AAMI PB70 — Liquid barrier performance for protective apparel. aami.org
  5. ISO 11135 — Sterilisation using ethylene oxide. iso.org
  6. EU NANDO — Notified Bodies database. ec.europa.eu

Deepen Your Knowledge

Visit our blog center for the full archive of medical supply guides and industry news.

Back to Blog Center